Securities code: 000972 securities abbreviation: * ST Zhongji Announcement No.: 2022-001
Chalkis Health Industry Co.Ltd(000972)
Performance forecast for 2021
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions. 1、 Expected performance of the current period
1. Performance forecast period: January 1, 2021 to December 31, 2021
2. Expected performance: ■ loss □ turning loss into profit □ rising in the same direction □ falling in the same direction
The current report of the project is the same period of last year
Loss: 120 million yuan – 80 million yuan
The net profit loss attributable to the shareholders of the listed company was 265892800 yuan, a decrease of 54.87% – 69.91% over the same period of the previous year
Loss: 115 million yuan – 75 million yuan
After deducting non recurring profits and losses, the net profit loss was 129.6826 million yuan, a decrease of 11.32% – 42.17% over the same period of the previous year
The operating income is 150 million yuan – 190 million yuan and 22.9661 million yuan
After deduction, the operating income is 142 million yuan – 182 million yuan and 86400 yuan
Loss of basic earnings per share: 0.15 yuan / share, 0.10 yuan / share, loss of 0.34 yuan / share
The owner’s equity attributable to the parent company is 60 million yuan – 90 million yuan and 176043800 yuan
Note: in the above table, the operating income after deduction refers to the operating income after deducting the business income irrelevant to the main business and the income without commercial substance.
2、 Communication with accounting firms
This performance forecast has not been pre audited by an accounting firm. The company has made pre communication with the accounting firm providing annual audit services for the company on this performance forecast, and there is no significant difference between the two sides on this performance forecast.
3、 Explanation of performance change reasons
In 2021, the company’s tomato industry has resumed production, and its wholly-owned subsidiary Xinjiang Zhongji Red Tomato Industry Co., Ltd. has organized and implemented production in an orderly manner, completed the production of large barrels of ketchup products and realized the sales of products. At the same time, in order to adjust and optimize the industrial chain structure of tomato products, the company has started to organize the recovery of the production and sales of lycopene health products and the preparation of small package ketchup, with a view to consolidating and developing the “red industry” of tomato. In addition, non recurring losses in the reporting period decreased compared with the same period of last year, resulting in a decrease in the total loss in the reporting period compared with the same period of last year.
4、 Risk tips
1. The relevant data of this performance forecast is the preliminary calculation result of the company’s financial department and has not been audited by an accounting firm. The specific financial data shall be subject to the 2021 annual report disclosed by the company.
2. The net profit of the company before and after deducting non recurring profits and losses in 2020 is negative, and the annual operating revenue is less than 100 million yuan. According to the relevant provisions of the stock listing rules of Shenzhen Stock Exchange (revised in 2020), Shenzhen Stock Exchange implements the “delisting risk warning” for the company’s stock trading. The net profit of the company before and after deducting non recurring profits and losses in the last three years, whichever is lower, is negative, and the audit report of this year shows that there is uncertainty in the company’s sustainable operation ability. According to the relevant provisions of the stock listing rules of Shenzhen Stock Exchange, Shenzhen stock exchange implements “other risk warning” for the company’s stock trading.
According to the provisions of the Listing Rules of Shenzhen Stock Exchange (revised in 2022): after the delisting risk warning is implemented for the stock trading of a listed company due to the circumstances in items (I) to (III) of paragraph 1 of article 9.3.1 of these rules, one of the following circumstances occurs in the first accounting year, Shenzhen stock exchange decides to terminate the listing and trading of its shares: (I) the audited net profit is negative and the operating income is less than 100 million yuan, or the net profit of the most recent fiscal year is negative and the operating income is less than 100 million yuan after retroactive restatement; (II) the audited ending net assets are negative, or the ending net assets of the latest fiscal year after retroactive restatement are negative; (III) audit reports with qualified opinions, unable to express opinions or negative opinions are issued in the financial and accounting reports; (IV) failing to disclose the annual report guaranteed by more than half of the directors to be true, accurate and complete within the statutory time limit; (V) although it complies with the provisions of article 9.3.7, it fails to apply to the exchange for cancellation of delisting risk warning within the specified time limit; (VI) due to non-compliance with article 9.3.7, the delisting risk warning application was not reviewed and approved by the exchange.
After the company’s retroactive restatement leads to the occurrence of items (I) and (II) of paragraph 1 of article 9.3.1 of these rules, or the delisting risk warning is implemented for its stock trading due to the occurrence of item (IV) of paragraph 1 of article 9.3.1, In case of any of the circumstances in items (IV) to (VI) of the preceding paragraph or any of the circumstances in items (I) to (III) of the preceding paragraph in the year next to the year corresponding to the delisting risk warning index, the Shenzhen Stock Exchange shall decide to terminate the listing and trading of its shares. Please pay attention to investment risks.
5、 Other relevant instructions
The information disclosure media designated by the company are securities times, securities daily and cninfo（ http://www.cn.info.com.cn. ）, all information of the company is subject to the official announcement published in the above designated media. Investors are invited to invest rationally and pay attention to investment risks.
It is hereby announced.
Chalkis Health Industry Co.Ltd(000972) board of directors January 20, 2022
